New issues in Ethics and Oncology International and
Transcrição
New issues in Ethics and Oncology International and
New issues in Ethics and Oncology 520 505 506 Phys.Chemie 9 he 26 304 320 281 261 241 222 110 H 111 119 119 132 LIZ 105 2 112 P <> 117 H H Jahnstraße Uferstraße r> < Necka ny Hauptbahnhof Copyright: Medienzentrum Universitätsklinikum Heidelberg http://www.uniklinikum-hd.de H P 27 30 17 18 19 20a 21 Bunsenplatz H he Berg r- e Adenau Platz P Römerkreis 28 Blum arstra Neck May 11 –im12 2012, Heidelberg aße er Str Römerstraße <> Ep pe lhe Cz er im br üc ke -haus Mittermaierstr. Landfried ID20600_Medienzentrum Universitätsklinikum Heidelberg 31 zstraße Bergheimer Straße 22 36 alstr. Vangerowstraße r. Weg aße Voßs29tr aße Wieblinge r P 25 26 Fehren Bildungszentrum im Heinsteinwerk St autstr er H lle Stadtha H ße nstra Sofieckar Bism latz P eim 24 it Hosp nh r. anst urm Sch20 23a 35 23 Thib an Ernst-WalzBrücke Stauwehr M i enhe Neu 100 UBA Max-Planck-Institut <> M ann Flugh heim afe A 656 n Bismarcksäule rTheodo HeussBrücke The organizers thank the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) for giving a grant for the conference and Böhringer Ingelheim GmbH for sponsoring. P 223 DKFZ UBA 221 220 130 133/ 134 H 260 240 Kirschnerstraße 131 P 242 280 370 H P fstraße Mönchho Bunsengasse P e rbach ren Nie 159 151 3 P P P 226 INF 306 ZMBH 282 Gästehaus tell hlstr. 162 m tru im he nn Ma 153 156 Physik 243 Tumorvirologie 32 H ks mü Schneid 360 9 Ta n Umweltphysik 229 H Mensa 154 155 zen 0 Garten 34he sc r Botani 10 267 7051 Geogr. Institut Zoologisches Institut 230 <> Ro h H P 8 te Luisenstr. 324 231 itu Straße 305 325 Blutbank 344b st acher LIZ 1 165 160 306 344a INF 410 161 326 345 365 Med Klin . ik 346 In Brückenstraße ZOO 366 364 425 H 307 78 114 P 327 34 115 aße nstr 410 347 -2 288 arte 367 11 Hörsaal 308 Mathem. Institut 328 235 Rohrb 348 0 227 368 15 isc 234 Geologie Hörsäle Chemie em INF 366 INF 344a INF 350 INF 670 INF 672 Speyerer Str. 4 INF 450 INF 671 INF 370/371 INF 346 INF 460 New issues in Ethics and Oncology 15 International and 16 32 multidisciplinary expert meeting 34 37 e straß enthal Blum H 236 Mineralogie 252 Ch 27 P 253/ 254 232 293/ 292 Südasieninstitut 330 im ss H Im Neuenheimer Feld H H H Saturday, 12(INF) May: Heidelberg University Hospital, P P Medical 400 Departments, 350 lecture hall, 12 450 Neuenheimer Im Feld 410, 69120 Heidelberg 1 Tierg DJH 521 501 Bioquant H Mathematik URZ 294 37 460 430 3a TSG 502 ße P 523 Wohnheime 522 503 500 H P MPI für Völkerrecht 535 stra H 536 560 and 676 - 683 561 Pädagogische Hochschule INF 305 rL ime 562 10 11 11a 12 13 14 524 504 17 Familientherapie 18 Frauenklinik (Pforte 19 Brustzentrum/ Onko 20 Arbeits-,Sozialmed 20a Klinische Sozialme 21 Medizinische Psych 22 Hautklinik 23 Rechts-,Verkehrsm 23a Rechts-,Verkehrsm 24 Psychiatrische Amb 25 Psychosomatische 26 Psychiatrische Klin 27 Prinzhornsammlung 28 Kinderpsychiatrie 29 Betriebsärztlicher D 30 Psychosom. Klinik/ 31 Bildungszentrum 35 KKS 36 Allg.Med / Vers.fors Institute for History and Ethics of Medicine she H Medical Faculty Heidelberg huh ße 671 Venue Friday, 1113 May: Theoretikum, lecture hall 2, Wohnheime P P 670 Im Neuenheimer672Feld 306, 69120 Heidelberg 14 P DKFZ P 530 Technologiepark 515 P INF 400 INF 410 INF 153 INF 430 INF 131 INF 110 INF 220/221 INF 280 INF 324 dsc nstra P Klinikum Bergh Kopfklinik Medizinische Klinik Kinderklinik (alt) Kinderklinik (Neubau) Schmerzzentrum Chirurgische Klinik Pathologisches Institut DKFZ Hygieneinstitut Institut für Immunologie Med. Biometrie u. Informatik Theoretikum Institut für Humangenetik Genetische Poliklinik Otto Meyerhof Zentrum VZM / Apotheke Verwaltung / ZIM ZIM Ionentherapie/HIT Zentrallabor Gästehaus Studiendekanat NCT Han 16 arte Schwimmbad 581 582 516-519 Hubschrauberlandeplatz Kla Sportanlagen Universität 3 he Tech 583 7050 700 Institut für Sport und Sportwissenschaften B park 584 gie nolo HTC 1 2 3 3a 4 5 6 7 8 9 en Olympiastützpunkt Rhein-Neckar Bundesleistungszentrum Berlinerstraße P H Klinikum Neuenheim Do 710 720 << Organisers Institute for History and Ethics of Medicine, Heidelberg University and National Center for Tumor Diseases (NCT), Heidelberg University Hospital Contact Prof. Dr. Monika Bobbert (+49 6221-545458) or Dr. Beate Herrmann (+49 6221-5637922); Institute for History and Ethics of Medicine, Im Neuenheimer Feld 327 69120 Heidelberg E-Mail: [email protected] http://www.medgesch.uni-hd.de/ pfad usen Tierg Main Speakers Vihjalmur Arnason, Reykjavik Monika Bobbert, Heidelberg Wolfgang U. Eckart, Heidelberg Doris Fölsch, Hallein Hille Haker, Chicago Mats G. Hansson, Uppsala Beate Herrmann, Heidelberg Frauke Ishorst-Witte, Hamburg Patrick Jahn, Halle Steven Joffe, Boston, Cambridge Wolf Dieter Ludwig, Berlin Oliver Rauprich, Bochum Dorothy E. Roberts, Chicago Jan Schildmann, Bochum Thomas Strowitzki, Heidelberg Antonella Surbone, New York, Rome Ulrich Wedding, Jena Eva Winkler, Heidelberg. enstr . Archiv t-Anl Eber rHich- Fried >>Sc s>> hlos New issues in Ethics and Oncology Friday 11 May 2012 Affordability of new cancer therapies: the rationing debate in Oncology 9.00 - 09.20 Words of welcome, introduction Communication & end-of-life decision making 9.20 - 10.00 Communication is the key: can it be trained, taught and assessed? Antonella Surbone, New York, Rome 10.00 - 10.40 Changing therapeutic targets? Erbitux and Avastin as an example Wolfgang U. Eckart, Heidelberg 10.40 - 10.55 Coffee break 10.55 - 11.35 Empirical and ethical aspects of tumor-specific therapies in patients at an advanced stage Eva Winkler, Heidelberg 11.35 - 12.15 Ethical criteria for treatment decisions in critically ill cancer patients, who are no longer capable of giving consent Monika Bobbert, Beate Herrmann, Heidelberg 12.15 - 12.45 Ethical implications of terminally ill patients’ wishes to die: Why it is important to understand the narratives Kathrin Ohnsorge, Heike Gudat, Christoph Rehmann-Sutter 12.45 - 14.00 Lunch Individualized Medicine: targeted therapies, biobanks and genomic analysis 14.00 - 14.40 Genetic testing in cancer therapy Mats G. Hansson, Uppsala 14.40 - 15.20 Biobanks and genomic approaches to cancer research: experiences from Iceland about the problems of biobanks and genetic research Vihjalmur Arnason, Reykjavik 15.20 - 15.50 Ethical aspects of individualized rectal cancer therapy: the relevance of socioempirical findings regarding physicians’ risk assessment S. Wöhlke, A. Hessling, S. Schicktanz, Göttingen 15.50 - 16.10 Coffee break 16.10 - 16.50 Is there rationing in cancer care? Jan Schildmann, Bochum 16.50 - 17.30 Qualitative interview study on rationing debate and ethical analysis Oliver Rauprich, Bochum Nursing care in oncology 17.30 - 18.10 Ethical issues of oncology nursing (overview) Doris Fölsch, Hallein (Austria) 18.10 - 18.50 Standards of Care in Oncology Patrick Jahn, Halle Saturday 12 May 2012 Vulnerable patient groups 9.00 - 9.40 9.40 - 10.20 10.20 - 10.40 10.40 - 11.10 11.10 - 11.40 11.40 - 13.00 Challenges in the care of homeless cancer patients Frauke Ishorst-Witte, Hamburg The care of cancer patients in view of human vulnerability Hille Haker, Chicago Coffee break Duties of children? Ethical aspects of the well-being of minors who donate blood stem cells to their siblings Christina Schües, Lübeck Children’s interests and rights between the doctor, the parents and the state Christoph Schickhardt, Düsseldorf Lunch Fertility preservation 13.00 - 13.40 Medical and ethical issues of new forms of fertility preservation in cancer patients Thomas Strowitzki, Heidelberg 13.40 - 14.20 Ethical and legal questions in the emerging field of oncofertility Dorothy E. Roberts, Chicago 14.20 - 14.50 Discussion of a key-concept of ethics using the example of fertility preservation in young cancer patients Bettina Boettcher, Innsbruck 14.50 - 15.10 Coffee break 15.10 - 15.50 Ethical issues in geriatric oncology Ulrich Wedding, Jena Clinical cancer research: opportunities, risks, perspectives 15.50 - 16.30 Frequency and effects of conflicts of interest in clinical trials Steven Joffe, Boston, Cambridge 16.30 - 17.10 Evidence and ethics in oncological trials Wolf Dieter Ludwig, Berlin 17.10 - 17.50 Benefit-risk-assessment and informed consent from patients in clinical research Steven Joffe, Boston, Cambridge 17.50 - 18.00 Conclusions, conference’s end